David J Arnold

Title: The Innovative Contributions of David J. Arnold

Introduction

David J. Arnold is an accomplished inventor based in South San Francisco, California. Known for his innovative contributions in the field of pharmacology, he has a keen focus on developing novel therapeutic agents. His work primarily revolves around the C-C chemokine receptor type 4 antagonists, which hold significant potential in treating various diseases.

Latest Patents

Arnold holds one patent under his name, titled "Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof." This patent encompasses crystalline forms of a C-C chemokine receptor type 4 (CCR4) antagonist, as well as oral dosage forms and methods of preparation and usage. The advancements in this patent aim to enhance the efficiency and effectiveness of treatments relying on these antagonists.

Career Highlights

David J. Arnold is currently associated with Rapt Therapeutics, Inc., a biotechnology company dedicated to delivering innovative therapeutic solutions. His expertise and contributions have been invaluable to the research and development teams within the organization, helping to drive projects that focus on novel small molecules and biologics.

Collaborations

Arnold works alongside skilled professionals, including his coworker Duane E. Rudisill, who collaborates with him on various projects. Their partnership contributes significantly to advancing their collective goals in developing new therapeutic agents, showcasing the impact of teamwork in fostering innovation in the industry.

Conclusion

David J. Arnold exemplifies the spirit of innovation and dedication within the biotechnology field. With his patent related to C-C chemokine receptor type 4 antagonists, he aims to contribute positively to medical advancements. His work at Rapt Therapeutics, Inc. firmly establishes him as a leading figure in researching and developing effective therapies for patients in need.